Results 71 to 80 of about 701,572 (291)
Gene Therapy in Cardiac Arrhythmias [PDF]
Gene therapy has progressed from a dream to a bedside reality in quite a few human diseases. From its first application in adenosine deaminase deficiency, through the years, its application has evolved to vascular angiogenesis and cardiac arrhythmias.
Francis, Johnson +2 more
core
Syncope in Patients with Cardiac Pacemakers
Introduction: It is challenging to diagnose syncope in patients with pacemakers. Because these patients have increased morbidity and mortality risks, they require immediate attention to determine the causes in order to provide appropriate treatment. This
Gisele Schineider Cunha (14656487) +9 more
core +1 more source
ABSTRACT Contemporary anatomical research has become increasingly integrated with clinical practice, generating substantial benefits for patient care and strengthening the translational relevance of the discipline. At the same time, some of the most influential anatomical advances have emerged from investigations whose eventual significance could not ...
Joe Iwanaga, Shane Tubbs
wiley +1 more source
Indications for and management of cardiac pacemakers
Cardiac pacemakers are now at the forefront of medical technology. The ability to provide pacing therapy adapted to the individual patient has resulted in significant patient benefit.
Luceri, Richard M, Myerburg, Robert J
core +1 more source
ABSTRACT Background Hypertrophic cardiomyopathy is associated with alterations in coronary microvascular function which have variable pathophysiologic mechanisms, and variable reversibility acutely and chronically following alcohol septal ablation (ASA).
Vojko V. Misevic +12 more
wiley +1 more source
Cardiac Pacemakers: A Closer Look at Technological Innovations
The use of technology in medical sciences, specifically the use of embedded technology to correct dysfunctional organs closer to their natural state, found its place with the great cardiac surgeons from the early 1900’s like Dr.
Paulo Leocadio (13784512)
core +1 more source
Transcatheter Tricuspid Valve Replacement for Residual Tricuspid Regurgitation After TEER
ABSTRACT Background Residual or recurrent tricuspid regurgitation (TR) after prior transcatheter tricuspid edge‐to‐edge (T‐TEER) repair occurs in about 12% of patients within 1 year. Since surgical tricuspid valve repair or replacement is of high risk, treatment options remain scarce.
Fabian Voß +14 more
wiley +1 more source
Complications of Implantation of Cardiovascular Implantable Electronic Device
Introduction: Cardiovascular implantable electronic devices (CIEDs), including pacemakers, implantable cardioverter-defibrillators (ICDs), and cardiac resynchronization therapy (CRT) devices, are crucial for managing various cardiac conditions. However,
Ormir Shurdha, Endri Hasimi, Mirald Gina
doaj +1 more source
Cardiac Pacemakers: The Route to Implantable Artificial Intelligence
Since the dawn of the 20th century, the field of medical science has undergone remarkable advancements, largely driven by the integration of technology. Notably, the utilization of embedded technology to restore malfunctioning organs to a state closer to
Paulo Leocadio (13784512)
core +1 more source
Interventional Mitral Valve Edge‐to‐Edge Repair in Patients Above 85 Years of Age
ABSTRACT Background Mitral valve transcatheter‐edge‐to‐edge repair (M‐TEER) is routinely performed in patients with severe mitral regurgitation (MR) at high operative risk, frequently including elderly patients. Patients ≥ 85 years, however, are frequently excluded in clinical studies.
Florian Jürgens +8 more
wiley +1 more source

